Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis

Dirk Bassler · 2010
DOI: 10.1001/jama.2010.310

Excerpts

Nontruncated RCTs with no evidence of benefit … would on average be associated with a 29% relative risk reduction in truncated RCTs addressing the same question.

— Page 1184

Reference

Dirk Bassler “Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis” (2010) DOI: 10.1001/jama.2010.310

@Article{bassler2010,
  title = {Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis},
  volume = {303},
  issn = {0098-7484},
  url = {http://dx.doi.org/10.1001/jama.2010.310},
  doi = {10.1001/jama.2010.310},
  number = {12},
  journal = {JAMA},
  publisher = {American Medical Association (AMA)},
  author = {Bassler, Dirk},
  year = {2010},
  month = {mar},
  pages = {1180}
}